Greylock XI GP Limited Partnership
Follow13F filer, CIK 1351699, CAMBRIDGE, MA
Greylock XI GP Limited Partnership reported $1,068,000 across 1 holding for the quarter ended 2014-06-30, in a 13F-HR filed 2014-07-14.
Filed (acceptance time not in the bulk data set), ingested 13F-HR 0000950123-14-007130
- Period
- 2014-06-30
- Reported value
- $1.07M
- Holdings
- 1
- Top 10 weight
- 100%
- New
- 0
- Sold out
- 1
Largest buys vs the previous quarter
None.
Largest sells vs the previous quarter
| Security | Shares change | Approx. value |
|---|---|---|
| WORKDAY, INC.exited | -1,708,939 | -$156M |
Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.
Holdings, Q2 2014
Share positions as resolved from 13F-HR 0000950123-14-007130, largest first. % of portfolio is the value over $1,068,000, the sum of the share positions whose value is usable for ratios (method).
| Security | History | Shares | Value | % of portfolio | Change | Latest event | Timeline |
|---|---|---|---|---|---|---|---|
| AVEO PHARMACEUTICALS INCAVEO PHARMACEUTICALS INC | 584,004 | $1.07M | 100% | 0 |
Sold out in Q2 2014
Positions in the previous quarter's report that this quarter's report no longer lists.
| Security | Shares before | Value before | Type |
|---|---|---|---|
| WORKDAY, INC.WORKDAY, INC. | 1,708,939 | $156M | shares |
How Q2 2014 was built
Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).
| Filing | Role | Amendment | Filed | Accepted | Ingested |
|---|---|---|---|---|---|
| 13F-HR 0000950123-14-007130 | base | 2014-07-14 | acceptance time not in the bulk data set |